Deakin University
Browse

File(s) not publicly available

The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trial

Version 2 2024-06-19, 15:12
Version 1 2023-02-10, 01:51
journal contribution
posted on 2024-06-19, 15:12 authored by SM Stick, A Foti, RS Ware, HAWM Tiddens, BS Clements, DS Armstrong, H Selvadurai, A Tai, PJ Cooper, CA Byrnes, Y Belessis, C Wainwright, A Jaffe, P Robinson, L Saiman, PD Sly
The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trial

History

Journal

The Lancet Respiratory Medicine

Volume

10

Pagination

776-784

Location

England

Publisher DOI

ISSN

2213-2600

eISSN

2213-2619

Language

en

Author URL

Publication classification

C1.1 Refereed article in a scholarly journal

Issue

8

Publisher

Elsevier BV

Publication URL

Usage metrics

    Research Publications

    Categories

    Keywords

    Anti-Bacterial AgentsAzithromycinBronchiectasisChildChild, PreschoolCystic FibrosisDouble-Blind MethodHumansInfantInfant, NewbornInflammationInterleukin-8Leukocyte Elastase

    Licence

    All Rights Reserved

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC